Le Lézard
Classified in: Health
Subjects: CHI, SVY, LEG, CFG

Government of Canada announces Vaping Products Reporting Regulations


OTTAWA, ON, June 21, 2023 /CNW/ - The Government of Canada is taking new steps to better understand the rapidly evolving vaping market as well as the impact that vaping can have on people's health.

Today, the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced Vaping Products Reporting Regulations. These regulations require manufacturers to disclose information about their sales and the ingredients used in their vaping products to Health Canada. Timely access to this data will help inform the development of policies and regulations to better protect people from the health risks of vaping and nicotine addiction, especially young persons and people who do not smoke.

These regulations build on investments in public education, regulation, and enforcement, and will help to address findings from the first legislative review of the Tobacco and Vaping Products Act. Specifically, they will help address scientific and product uncertainty to better understand the vaping product market and the health impacts of vaping.

The Vaping Products Reporting Regulations are similar to the Tobacco Reporting Regulations, in that they continue to provide Health Canada with information to help make policy decisions and develop effective tobacco control strategies. Health Canada is considering future additional changes to the vaping product reporting requirements that would enhance ongoing research and data collection activities and create even greater alignment with those in place for tobacco product manufacturers.

Quotes

"We need to better understand the rapidly evolving vaping market and the impact of vaping product use on health, especially the health of young people. The data collected through these new regulations will help inform policies and programs that further the objectives of Canada's Tobacco Strategy, including actions to decrease youth vaping rates and helping people who smoke quit tobacco."

The Honourable Carolyn Bennett
Minister of Mental Health and Addiction and Associate Minister of Health 

"Vaping, especially among youth, is a serious public health concern. This new measure is an important step in strengthening policies and regulations to protect young people and people who do not smoke from the harm of vaping and nicotine addiction. We will continue to use all tools at our disposal to protect everyone from the negative health impacts of vaping and nicotine."

The Honourable Jean-Yves Duclos
Minister of Health 

Quick Facts
Associated Links

Vaping Products Reporting Regulations ? Canada Gazette Part II 
Regulating tobacco and vaping products
Canada's Tobacco Strategy

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 08:40
Babson Diagnostics, a science-first health care technology company, today announced a partnership with Cynergy Wellness, Inc., a privately-owned provider of nationwide physician services for workplace screening and consumer health. Under the terms of...

at 08:37
The Seven Cells team is delighted to re-introduce Tirzepatide, their latest innovation in telehealth pharmacy services. Tirzepatide, featuring the same active ingredient found in the esteemed medications Mounjaro and ZepBound, represents a...

at 08:35
PAVmed Inc.  ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and...

at 08:33
California Vitality, a dynamic new brand offering a range of high-quality supplements, is thrilled to announce its official launch. With a focus on promoting holistic wellness, California Vitality aims to empower individuals to take control of their...

at 08:15
The latest product innovation by NICO Corporation is described as a "game-changing advancement" by neurosurgeons with early experience using the NICO Myriad SPECTRA System ? the ONLY hand-held technology delivering blue excitation light to enhance...

at 08:05
Ventus Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing its proprietary structural biology and computational chemistry platform, ReSOLVEtm, to develop differentiated small molecule therapeutics, today announced that its...



News published on and distributed by: